The global market for Peritoneal Dialysis Formulations was valued at US$ 742 million in the year 2024 and is projected to reach a revised size of US$ 1054 million by 2031, growing at a CAGR of 5.1% during the forecast period.

Peritoneal Dialysis Formulations Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Peritoneal Dialysis Formulations competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Peritoneal Dialysis Formulations refer to sterile solutions or preparations used in peritoneal dialysis therapy, which are infused into the patient’s peritoneal cavity through a catheter. Utilizing the peritoneum as a natural semipermeable membrane, these formulations facilitate the removal of excess fluid and metabolic waste products. They typically contain osmotic agents such as glucose, amino acids, or icodextrin, combined with electrolytes and buffering systems (e.g., lactate or bicarbonate) to maintain osmotic pressure, acid-base balance, and electrolyte stability during dialysis. Depending on their composition, peritoneal dialysis formulations are classified into glucose-based, amino acid-based, and icodextrin-based solutions, and are widely used for patients with end-stage renal disease or those requiring long-term dialysis. In 2024, the global sales volume of peritoneal dialysis formulations was 114.1 million units, with an average price of 6.5 USD per unit.

1. Regional Market Landscape

In 2024, North America accounts for around 34% of the global market, with the United States and Canada as the major countries, benefiting from comprehensive healthcare coverage and widespread home dialysis adoption. The Asia-Pacific region accounts for approximately 38%, with China, Japan, and India as key countries, driven by supportive policies and strong local manufacturing capabilities. Europe holds roughly 27% of the market, mainly Germany, France, and Italy, supported by mature healthcare systems. The Middle East and Africa represent about 9%, constrained by limited infrastructure and training resources.

2. Manufacturers and Industry Chain Analysis

Upstream mainly includes raw material suppliers providing key chemicals such as glucose, amino acids, and icodextrin, as well as manufacturers of equipment for dialysis solution preparation and packaging. The midstream is dominated by Baxter, Fresenius Medical Care, and Terumo, collectively accounting for approximately 87% of the market, with Baxter holding around 69%. Downstream distribution channels include hospitals, dialysis centers, and home care services, with end-users primarily being end-stage renal disease patients opting for peritoneal dialysis.

3. Technology Trends and Innovations

Key technological trends include: 1) Automated Peritoneal Dialysis (APD) systems that automatically exchange dialysis fluid overnight, enhancing patient quality of life; 2) Smart monitoring and telemedicine solutions enabling real-time monitoring and data analysis during dialysis; 3) New dialysis fluid formulations with low glucose, low calcium, and low sodium to reduce side effects; 4) Portable dialysis devices allowing patients to perform dialysis at home or while traveling.

4. Policy Support and Challenges

Policy support includes healthcare coverage for peritoneal dialysis fluids and equipment in the United States and Canada, public healthcare policies in China and India encouraging peritoneal dialysis to reduce hospital burden, and patient education and training programs in EU countries. Challenges include limited professional training resources affecting treatment outcomes, risks of peritonitis and catheter-related infections, potential supply chain disruptions impacting dialysis fluid availability, and variations in healthcare policies across countries limiting dialysis adoption.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peritoneal Dialysis Formulations, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peritoneal Dialysis Formulations.

The Peritoneal Dialysis Formulations market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peritoneal Dialysis Formulations market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peritoneal Dialysis Formulations manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peritoneal Dialysis Formulations Market Report

Report Metric	Details
Report Name	Peritoneal Dialysis Formulations Market
Accounted market size in year	US$ 742 million
Forecasted market size in 2031	US$ 1054 million
CAGR	5.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Glucose-based Peritoneal Dialysis Solution Amino Acid-based Peritoneal Dialysis Solution Icodextrin Peritoneal Dialysis Solution
Segment by Application	Hospital Clinic Dialysis Center
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Baxter, Fresenius, B. Braun, WEGO, Huaren Pharmaceutical, CR Double-Crane, Qingshan Likang, SSY Group, Wuhu Daorun Pharmaceuticals, Pharmasyntez Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peritoneal Dialysis Formulations manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peritoneal Dialysis Formulations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Peritoneal Dialysis Formulations Market growing?

Ans: The Peritoneal Dialysis Formulations Market witnessing a CAGR of 5.1% during the forecast period 2025-2031.

What is the Peritoneal Dialysis Formulations Market size in 2031?

Ans: The Peritoneal Dialysis Formulations Market size in 2031 will be US$ 1054 million.

What is the Peritoneal Dialysis Formulations Market share by region?

Ans: Regional Market Landscape In 2024, North America accounts for around 34% of the global market, with the United States and Canada as the major countries, benefiting from comprehensive healthcare coverage and widespread home dialysis adoption. Europe holds roughly 27% of the market, mainly Germany, France, and Italy, supported by mature healthcare systems. The Middle East and Africa represent about 9%, constrained by limited infrastructure and training resources.

Who are the main players in the Peritoneal Dialysis Formulations Market report?

Ans: The main players in the Peritoneal Dialysis Formulations Market are Baxter, Fresenius, B. Braun, WEGO, Huaren Pharmaceutical, CR Double-Crane, Qingshan Likang, SSY Group, Wuhu Daorun Pharmaceuticals, Pharmasyntez Group

What are the Application segmentation covered in the Peritoneal Dialysis Formulations Market report?

Ans: The Applications covered in the Peritoneal Dialysis Formulations Market report are Hospital, Clinic, Dialysis Center

What are the Type segmentation covered in the Peritoneal Dialysis Formulations Market report?

Ans: The Types covered in the Peritoneal Dialysis Formulations Market report are Glucose-based Peritoneal Dialysis Solution, Amino Acid-based Peritoneal Dialysis Solution, Icodextrin Peritoneal Dialysis Solution

1 Peritoneal Dialysis Formulations Market Overview

1.1 Product Definition

1.2 Peritoneal Dialysis Formulations by Type

1.2.1 Global Peritoneal Dialysis Formulations Market Value Comparison by Type (2024 VS 2031)

1.2.2 Glucose-based Peritoneal Dialysis Solution

1.2.3 Amino Acid-based Peritoneal Dialysis Solution

1.2.4 Icodextrin Peritoneal Dialysis Solution

1.3 Peritoneal Dialysis Formulations by Application

1.3.1 Global Peritoneal Dialysis Formulations Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Dialysis Center

1.4 Global Peritoneal Dialysis Formulations Market Size Estimates and Forecasts

1.4.1 Global Peritoneal Dialysis Formulations Revenue 2020-2031

1.4.2 Global Peritoneal Dialysis Formulations Sales 2020-2031

1.4.3 Global Peritoneal Dialysis Formulations Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Peritoneal Dialysis Formulations Market Competition by Manufacturers

2.1 Global Peritoneal Dialysis Formulations Sales Market Share by Manufacturers (2020-2025)

2.2 Global Peritoneal Dialysis Formulations Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Peritoneal Dialysis Formulations Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Peritoneal Dialysis Formulations, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Peritoneal Dialysis Formulations, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Peritoneal Dialysis Formulations, Product Type & Application

2.7 Global Key Manufacturers of Peritoneal Dialysis Formulations, Date of Enter into This Industry

2.8 Global Peritoneal Dialysis Formulations Market Competitive Situation and Trends

2.8.1 Global Peritoneal Dialysis Formulations Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Peritoneal Dialysis Formulations Players Market Share by Revenue

2.8.3 Global Peritoneal Dialysis Formulations Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Peritoneal Dialysis Formulations Market Scenario by Region

3.1 Global Peritoneal Dialysis Formulations Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Peritoneal Dialysis Formulations Sales by Region: 2020-2031

3.2.1 Global Peritoneal Dialysis Formulations Sales by Region: 2020-2025

3.2.2 Global Peritoneal Dialysis Formulations Sales by Region: 2026-2031

3.3 Global Peritoneal Dialysis Formulations Revenue by Region: 2020-2031

3.3.1 Global Peritoneal Dialysis Formulations Revenue by Region: 2020-2025

3.3.2 Global Peritoneal Dialysis Formulations Revenue by Region: 2026-2031

3.4 North America Peritoneal Dialysis Formulations Market Facts & Figures by Country

3.4.1 North America Peritoneal Dialysis Formulations Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Peritoneal Dialysis Formulations Sales by Country (2020-2031)

3.4.3 North America Peritoneal Dialysis Formulations Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Peritoneal Dialysis Formulations Market Facts & Figures by Country

3.5.1 Europe Peritoneal Dialysis Formulations Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Peritoneal Dialysis Formulations Sales by Country (2020-2031)

3.5.3 Europe Peritoneal Dialysis Formulations Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Peritoneal Dialysis Formulations Market Facts & Figures by Region

3.6.1 Asia Pacific Peritoneal Dialysis Formulations Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Peritoneal Dialysis Formulations Sales by Region (2020-2031)

3.6.3 Asia Pacific Peritoneal Dialysis Formulations Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Peritoneal Dialysis Formulations Market Facts & Figures by Country

3.7.1 Latin America Peritoneal Dialysis Formulations Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Peritoneal Dialysis Formulations Sales by Country (2020-2031)

3.7.3 Latin America Peritoneal Dialysis Formulations Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Peritoneal Dialysis Formulations Market Facts & Figures by Country

3.8.1 Middle East and Africa Peritoneal Dialysis Formulations Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Peritoneal Dialysis Formulations Sales by Country (2020-2031)

3.8.3 Middle East and Africa Peritoneal Dialysis Formulations Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Peritoneal Dialysis Formulations Sales by Type (2020-2031)

4.1.1 Global Peritoneal Dialysis Formulations Sales by Type (2020-2025)

4.1.2 Global Peritoneal Dialysis Formulations Sales by Type (2026-2031)

4.1.3 Global Peritoneal Dialysis Formulations Sales Market Share by Type (2020-2031)

4.2 Global Peritoneal Dialysis Formulations Revenue by Type (2020-2031)

4.2.1 Global Peritoneal Dialysis Formulations Revenue by Type (2020-2025)

4.2.2 Global Peritoneal Dialysis Formulations Revenue by Type (2026-2031)

4.2.3 Global Peritoneal Dialysis Formulations Revenue Market Share by Type (2020-2031)

4.3 Global Peritoneal Dialysis Formulations Price by Type (2020-2031)

5 Segment by Application

5.1 Global Peritoneal Dialysis Formulations Sales by Application (2020-2031)

5.1.1 Global Peritoneal Dialysis Formulations Sales by Application (2020-2025)

5.1.2 Global Peritoneal Dialysis Formulations Sales by Application (2026-2031)

5.1.3 Global Peritoneal Dialysis Formulations Sales Market Share by Application (2020-2031)

5.2 Global Peritoneal Dialysis Formulations Revenue by Application (2020-2031)

5.2.1 Global Peritoneal Dialysis Formulations Revenue by Application (2020-2025)

5.2.2 Global Peritoneal Dialysis Formulations Revenue by Application (2026-2031)

5.2.3 Global Peritoneal Dialysis Formulations Revenue Market Share by Application (2020-2031)

5.3 Global Peritoneal Dialysis Formulations Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Baxter

6.1.1 Baxter Company Information

6.1.2 Baxter Description and Business Overview

6.1.3 Baxter Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Baxter Peritoneal Dialysis Formulations Product Portfolio

6.1.5 Baxter Recent Developments/Updates

6.2 Fresenius

6.2.1 Fresenius Company Information

6.2.2 Fresenius Description and Business Overview

6.2.3 Fresenius Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Fresenius Peritoneal Dialysis Formulations Product Portfolio

6.2.5 Fresenius Recent Developments/Updates

6.3 B. Braun

6.3.1 B. Braun Company Information

6.3.2 B. Braun Description and Business Overview

6.3.3 B. Braun Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.3.4 B. Braun Peritoneal Dialysis Formulations Product Portfolio

6.3.5 B. Braun Recent Developments/Updates

6.4 WEGO

6.4.1 WEGO Company Information

6.4.2 WEGO Description and Business Overview

6.4.3 WEGO Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.4.4 WEGO Peritoneal Dialysis Formulations Product Portfolio

6.4.5 WEGO Recent Developments/Updates

6.5 Huaren Pharmaceutical

6.5.1 Huaren Pharmaceutical Company Information

6.5.2 Huaren Pharmaceutical Description and Business Overview

6.5.3 Huaren Pharmaceutical Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Huaren Pharmaceutical Peritoneal Dialysis Formulations Product Portfolio

6.5.5 Huaren Pharmaceutical Recent Developments/Updates

6.6 CR Double-Crane

6.6.1 CR Double-Crane Company Information

6.6.2 CR Double-Crane Description and Business Overview

6.6.3 CR Double-Crane Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.6.4 CR Double-Crane Peritoneal Dialysis Formulations Product Portfolio

6.6.5 CR Double-Crane Recent Developments/Updates

6.7 Qingshan Likang

6.7.1 Qingshan Likang Company Information

6.7.2 Qingshan Likang Description and Business Overview

6.7.3 Qingshan Likang Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Qingshan Likang Peritoneal Dialysis Formulations Product Portfolio

6.7.5 Qingshan Likang Recent Developments/Updates

6.8 SSY Group

6.8.1 SSY Group Company Information

6.8.2 SSY Group Description and Business Overview

6.8.3 SSY Group Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.8.4 SSY Group Peritoneal Dialysis Formulations Product Portfolio

6.8.5 SSY Group Recent Developments/Updates

6.9 Wuhu Daorun Pharmaceuticals

6.9.1 Wuhu Daorun Pharmaceuticals Company Information

6.9.2 Wuhu Daorun Pharmaceuticals Description and Business Overview

6.9.3 Wuhu Daorun Pharmaceuticals Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Wuhu Daorun Pharmaceuticals Peritoneal Dialysis Formulations Product Portfolio

6.9.5 Wuhu Daorun Pharmaceuticals Recent Developments/Updates

6.10 Pharmasyntez Group

6.10.1 Pharmasyntez Group Company Information

6.10.2 Pharmasyntez Group Description and Business Overview

6.10.3 Pharmasyntez Group Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Pharmasyntez Group Peritoneal Dialysis Formulations Product Portfolio

6.10.5 Pharmasyntez Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Peritoneal Dialysis Formulations Industry Chain Analysis

7.2 Peritoneal Dialysis Formulations Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Peritoneal Dialysis Formulations Production Mode & Process Analysis

7.4 Peritoneal Dialysis Formulations Sales and Marketing

7.4.1 Peritoneal Dialysis Formulations Sales Channels

7.4.2 Peritoneal Dialysis Formulations Distributors

7.5 Peritoneal Dialysis Formulations Customer Analysis

8 Peritoneal Dialysis Formulations Market Dynamics

8.1 Peritoneal Dialysis Formulations Industry Trends

8.2 Peritoneal Dialysis Formulations Market Drivers

8.3 Peritoneal Dialysis Formulations Market Challenges

8.4 Peritoneal Dialysis Formulations Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Huaren Pharmaceutical

CR Double-Crane

Qingshan Likang

SSY Group

Wuhu Daorun Pharmaceuticals

Pharmasyntez Group

List of Tables

Table 1. Global Peritoneal Dialysis Formulations Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Peritoneal Dialysis Formulations Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Peritoneal Dialysis Formulations Market Competitive Situation by Manufacturers in 2024

Table 4. Global Peritoneal Dialysis Formulations Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Peritoneal Dialysis Formulations Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Peritoneal Dialysis Formulations Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Peritoneal Dialysis Formulations Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Peritoneal Dialysis Formulations Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Peritoneal Dialysis Formulations, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Peritoneal Dialysis Formulations, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Peritoneal Dialysis Formulations, Product Type & Application

Table 12. Global Key Manufacturers of Peritoneal Dialysis Formulations, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Peritoneal Dialysis Formulations by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peritoneal Dialysis Formulations as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Peritoneal Dialysis Formulations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Peritoneal Dialysis Formulations Sales by Region (2020-2025) & (K Units)

Table 18. Global Peritoneal Dialysis Formulations Sales Market Share by Region (2020-2025)

Table 19. Global Peritoneal Dialysis Formulations Sales by Region (2026-2031) & (K Units)

Table 20. Global Peritoneal Dialysis Formulations Sales Market Share by Region (2026-2031)

Table 21. Global Peritoneal Dialysis Formulations Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Peritoneal Dialysis Formulations Revenue Market Share by Region (2020-2025)

Table 23. Global Peritoneal Dialysis Formulations Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Peritoneal Dialysis Formulations Revenue Market Share by Region (2026-2031)

Table 25. North America Peritoneal Dialysis Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Peritoneal Dialysis Formulations Sales by Country (2020-2025) & (K Units)

Table 27. North America Peritoneal Dialysis Formulations Sales by Country (2026-2031) & (K Units)

Table 28. North America Peritoneal Dialysis Formulations Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Peritoneal Dialysis Formulations Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Peritoneal Dialysis Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Peritoneal Dialysis Formulations Sales by Country (2020-2025) & (K Units)

Table 32. Europe Peritoneal Dialysis Formulations Sales by Country (2026-2031) & (K Units)

Table 33. Europe Peritoneal Dialysis Formulations Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Peritoneal Dialysis Formulations Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Peritoneal Dialysis Formulations Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Peritoneal Dialysis Formulations Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Peritoneal Dialysis Formulations Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Peritoneal Dialysis Formulations Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Peritoneal Dialysis Formulations Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Peritoneal Dialysis Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Peritoneal Dialysis Formulations Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Peritoneal Dialysis Formulations Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Peritoneal Dialysis Formulations Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Peritoneal Dialysis Formulations Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Peritoneal Dialysis Formulations Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Peritoneal Dialysis Formulations Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Peritoneal Dialysis Formulations Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Peritoneal Dialysis Formulations Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Peritoneal Dialysis Formulations Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Peritoneal Dialysis Formulations Sales (K Units) by Type (2020-2025)

Table 51. Global Peritoneal Dialysis Formulations Sales (K Units) by Type (2026-2031)

Table 52. Global Peritoneal Dialysis Formulations Sales Market Share by Type (2020-2025)

Table 53. Global Peritoneal Dialysis Formulations Sales Market Share by Type (2026-2031)

Table 54. Global Peritoneal Dialysis Formulations Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Peritoneal Dialysis Formulations Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Peritoneal Dialysis Formulations Revenue Market Share by Type (2020-2025)

Table 57. Global Peritoneal Dialysis Formulations Revenue Market Share by Type (2026-2031)

Table 58. Global Peritoneal Dialysis Formulations Price (US$/Unit) by Type (2020-2025)

Table 59. Global Peritoneal Dialysis Formulations Price (US$/Unit) by Type (2026-2031)

Table 60. Global Peritoneal Dialysis Formulations Sales (K Units) by Application (2020-2025)

Table 61. Global Peritoneal Dialysis Formulations Sales (K Units) by Application (2026-2031)

Table 62. Global Peritoneal Dialysis Formulations Sales Market Share by Application (2020-2025)

Table 63. Global Peritoneal Dialysis Formulations Sales Market Share by Application (2026-2031)

Table 64. Global Peritoneal Dialysis Formulations Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Peritoneal Dialysis Formulations Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Peritoneal Dialysis Formulations Revenue Market Share by Application (2020-2025)

Table 67. Global Peritoneal Dialysis Formulations Revenue Market Share by Application (2026-2031)

Table 68. Global Peritoneal Dialysis Formulations Price (US$/Unit) by Application (2020-2025)

Table 69. Global Peritoneal Dialysis Formulations Price (US$/Unit) by Application (2026-2031)

Table 70. Baxter Company Information

Table 71. Baxter Description and Business Overview

Table 72. Baxter Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Baxter Peritoneal Dialysis Formulations Product

Table 74. Baxter Recent Developments/Updates

Table 75. Fresenius Company Information

Table 76. Fresenius Description and Business Overview

Table 77. Fresenius Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Fresenius Peritoneal Dialysis Formulations Product

Table 79. Fresenius Recent Developments/Updates

Table 80. B. Braun Company Information

Table 81. B. Braun Description and Business Overview

Table 82. B. Braun Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. B. Braun Peritoneal Dialysis Formulations Product

Table 84. B. Braun Recent Developments/Updates

Table 85. WEGO Company Information

Table 86. WEGO Description and Business Overview

Table 87. WEGO Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. WEGO Peritoneal Dialysis Formulations Product

Table 89. WEGO Recent Developments/Updates

Table 90. Huaren Pharmaceutical Company Information

Table 91. Huaren Pharmaceutical Description and Business Overview

Table 92. Huaren Pharmaceutical Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Huaren Pharmaceutical Peritoneal Dialysis Formulations Product

Table 94. Huaren Pharmaceutical Recent Developments/Updates

Table 95. CR Double-Crane Company Information

Table 96. CR Double-Crane Description and Business Overview

Table 97. CR Double-Crane Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. CR Double-Crane Peritoneal Dialysis Formulations Product

Table 99. CR Double-Crane Recent Developments/Updates

Table 100. Qingshan Likang Company Information

Table 101. Qingshan Likang Description and Business Overview

Table 102. Qingshan Likang Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Qingshan Likang Peritoneal Dialysis Formulations Product

Table 104. Qingshan Likang Recent Developments/Updates

Table 105. SSY Group Company Information

Table 106. SSY Group Description and Business Overview

Table 107. SSY Group Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. SSY Group Peritoneal Dialysis Formulations Product

Table 109. SSY Group Recent Developments/Updates

Table 110. Wuhu Daorun Pharmaceuticals Company Information

Table 111. Wuhu Daorun Pharmaceuticals Description and Business Overview

Table 112. Wuhu Daorun Pharmaceuticals Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Wuhu Daorun Pharmaceuticals Peritoneal Dialysis Formulations Product

Table 114. Wuhu Daorun Pharmaceuticals Recent Developments/Updates

Table 115. Pharmasyntez Group Company Information

Table 116. Pharmasyntez Group Description and Business Overview

Table 117. Pharmasyntez Group Peritoneal Dialysis Formulations Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Pharmasyntez Group Peritoneal Dialysis Formulations Product

Table 119. Pharmasyntez Group Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Peritoneal Dialysis Formulations Distributors List

Table 123. Peritoneal Dialysis Formulations Customers List

Table 124. Peritoneal Dialysis Formulations Market Trends

Table 125. Peritoneal Dialysis Formulations Market Drivers

Table 126. Peritoneal Dialysis Formulations Market Challenges

Table 127. Peritoneal Dialysis Formulations Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Peritoneal Dialysis Formulations

Figure 2. Global Peritoneal Dialysis Formulations Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Peritoneal Dialysis Formulations Market Share by Type: 2024 & 2031

Figure 4. Glucose-based Peritoneal Dialysis Solution Product Picture

Figure 5. Amino Acid-based Peritoneal Dialysis Solution Product Picture

Figure 6. Icodextrin Peritoneal Dialysis Solution Product Picture

Figure 7. Global Peritoneal Dialysis Formulations Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Peritoneal Dialysis Formulations Market Share by Application: 2024 & 2031

Figure 9. Hospital

Figure 10. Clinic

Figure 11. Dialysis Center

Figure 12. Global Peritoneal Dialysis Formulations Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Peritoneal Dialysis Formulations Market Size (2020-2031) & (US$ Million)

Figure 14. Global Peritoneal Dialysis Formulations Sales (2020-2031) & (K Units)

Figure 15. Global Peritoneal Dialysis Formulations Average Price (US$/Unit) & (2020-2031)

Figure 16. Peritoneal Dialysis Formulations Report Years Considered

Figure 17. Peritoneal Dialysis Formulations Sales Share by Manufacturers in 2024

Figure 18. Global Peritoneal Dialysis Formulations Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Peritoneal Dialysis Formulations Players: Market Share by Revenue in Peritoneal Dialysis Formulations in 2024

Figure 20. Peritoneal Dialysis Formulations Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Peritoneal Dialysis Formulations Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Peritoneal Dialysis Formulations Sales Market Share by Country (2020-2031)

Figure 23. North America Peritoneal Dialysis Formulations Revenue Market Share by Country (2020-2031)

Figure 24. United States Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Peritoneal Dialysis Formulations Sales Market Share by Country (2020-2031)

Figure 27. Europe Peritoneal Dialysis Formulations Revenue Market Share by Country (2020-2031)

Figure 28. Germany Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Peritoneal Dialysis Formulations Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Peritoneal Dialysis Formulations Revenue Market Share by Region (2020-2031)

Figure 35. China Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Peritoneal Dialysis Formulations Sales Market Share by Country (2020-2031)

Figure 43. Latin America Peritoneal Dialysis Formulations Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Colombia Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Middle East and Africa Peritoneal Dialysis Formulations Sales Market Share by Country (2020-2031)

Figure 49. Middle East and Africa Peritoneal Dialysis Formulations Revenue Market Share by Country (2020-2031)

Figure 50. Turkey Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. UAE Peritoneal Dialysis Formulations Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Global Sales Market Share of Peritoneal Dialysis Formulations by Type (2020-2031)

Figure 54. Global Revenue Market Share of Peritoneal Dialysis Formulations by Type (2020-2031)

Figure 55. Global Peritoneal Dialysis Formulations Price (US$/Unit) by Type (2020-2031)

Figure 56. Global Sales Market Share of Peritoneal Dialysis Formulations by Application (2020-2031)

Figure 57. Global Revenue Market Share of Peritoneal Dialysis Formulations by Application (2020-2031)

Figure 58. Global Peritoneal Dialysis Formulations Price (US$/Unit) by Application (2020-2031)

Figure 59. Peritoneal Dialysis Formulations Value Chain

Figure 60. Channels of Distribution (Direct Vs Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions